Publications

Articles

The regulatory effect of cabazitaxel on epithelial-mesenchymal transition in metastatic prostate cancer.

Eryılmaz I. E., Eskiler G. G., Egeli Ü., Çeçener G.
Journal of cancer research and therapeutics, vol.19, no.Supplement, 2023 (SCI-Expanded, Scopus) Sustainable Development identifier identifier

An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating.

Eryilmaz I. E., Egeli Ü., Cecener G.
Clinical and experimental pharmacology & physiology, vol.49, no.10, pp.1094-1104, 2022 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Investigation of VHL gene associated with miR-223 in clear cell renal cell carcinoma

Unal U., Çeçener G., Unlu H. T., Aytaç Vuruşkan B., Erdem E. E., Egeli Ü., et al.
MOLECULAR BIOLOGY REPORTS, vol.49, no.3, pp.2073-2083, 2022 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

The Activation of PI3K/AKT/mTOR Signaling Pathway in Response to Cabazitaxel Treatment in Metastatic Castration-Resistant Prostate Cancer Cells

ERYILMAZ I. E., GÜNEY ESKİLER G., Çolakoğlu C., EGELİ Ü., ÇEÇENER G.
European Journal of Biology, vol.80, no.2, pp.138-144, 2021 (TRDizin) Sustainable Development identifier

Association between the anticancer efficacy of cabazitaxel and toll-like receptor 4 mediating signaling pathways in metastatic castration-resistant prostate cancer cells.

Guney Eskiler G., Ozkan A. D., Eryilmaz I. E., Egeli Ü., Cecener G.
Human & experimental toxicology, vol.40, no.7, pp.1122-1129, 2021 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Philadelphia-like acute lymphoblastic leukemia in pediatric cases Pediatrik vakalarda philadelphia benzeri akut lenfoblastik lösemi

Erdem E. E., ÇEÇENER G., Ünlü H. T., Evim M. S.
Guncel Pediatri, vol.19, no.1, pp.141-150, 2021 (ESCI, Scopus) identifier identifier

Talazoparib nanoparticles for overcoming multidrug resistance in triple-negative breast cancer

Eskiler G. G., ÇEÇENER G., EGELİ Ü., TUNCA B.
JOURNAL OF CELLULAR PHYSIOLOGY, vol.235, no.9, pp.6230-6245, 2020 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Reversal effect of quercetin on talazoparib resistance in BRCA1 mutant triple negative breast cancer

GÜNEY ESKİLER G., ÇEÇENER G., EGELİ Ü., TUNCA B.
The European Research Journal, vol.6, no.1, pp.19-25, 2020 (TRDizin) Sustainable Development

Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients

ÇEÇENER G., Takanlou L. S., Takanlou M. S., EGELİ Ü., Eskiler G. G., AKSOY S., et al.
CANCER GENETICS, vol.240, pp.23-32, 2020 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Synergistic effects of hormone therapy drugs and usnic acid on hormone receptor-positive breast and prostate cancer cells

Eskiler G. G., ERYILMAZ I. E., Yurdacan B., EGELİ Ü., ÇEÇENER G., TUNCA B.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, vol.33, no.8, 2019 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid

Yurdacan B., Egeli Ü., Eskiler G. G., Eryılmaz I. E., Çeçener G., Tunca B.
JOURNAL OF PHARMACY AND PHARMACOLOGY, vol.71, no.7, pp.1119-1132, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile

Eskiler G. G., ÇEÇENER G., EGELİ Ü., TUNCA B.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, vol.33, no.5, 2019 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

RNA-based markers in biopsy cores with atypical small acinar proliferation: Predictive effect of T2E fusion positivity and MMP-2 upregulation for a subsequent prostate cancer diagnosis

Eryılmaz I. E., Aytaç Vuruşkan B., Kaygısız O., Egeli Ü., Tunca B., Kordan Y., et al.
PROSTATE, vol.79, no.2, pp.195-205, 2019 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Talazoparib Loaded Solid Lipid Nanoparticles: Preparation, Characterization and Evaluation of the Therapeutic Efficacy In Vitro

Eskiler G. G., ÇEÇENER G., DİKMEN G., EGELİ Ü., TUNCA B.
CURRENT DRUG DELIVERY, vol.16, no.6, pp.511-529, 2019 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Prediction of breast cancer metastasis risk using circulating tumor markers: A follow-up study

ÇETİNTAŞ S., Tezcan G., TUNCA B., EGELİ Ü., GÖKGÖZ M. Ş., ÇEÇENER G.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, vol.19, no.2, pp.172-179, 2019 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer

Eskiler G. G., ÇEÇENER G., EGELİ Ü., TUNCA B.
PHARMACEUTICAL RESEARCH, vol.35, no.11, 2018 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

In vitro cytotoxic and antiproliferative effects of usnic acid on hormone-dependent breast and prostate cancer cells

ERYILMAZ I. E., Eskiler G. G., EGELİ Ü., Yurdacan B., ÇEÇENER G., TUNCA B.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, vol.32, no.10, 2018 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer

Eskiler G. G., ÇEÇENER G., DİKMEN G., EGELİ Ü., TUNCA B.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol.120, pp.73-88, 2018 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Triple negative breast cancer: new therapeutic approaches and BRCA status

Eskiler G. G., ÇEÇENER G., EGELİ Ü., TUNCA B.
APMIS, vol.126, no.5, pp.371-379, 2018 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

T2E (TMPRSS2-ERG) fusion transcripts are associated with higher levels of AMACR mRNA and a subsequent prostate cancer diagnosis in patients with atypical small acinar proliferation

Eryılmaz I. E., Kordan Y., Aytaç Vuruşkan B., Kaygısız O., Tunca B., Çeçener G.
GENE, vol.645, pp.69-75, 2018 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Cytotoxicity of Juniperus excelsa Aqueous BerryExtract on Castration-Resistant Prostate CancerCells

Eryılmaz I. E., Egeli Ü., Malyer H., Çeçener G., Şahin S., Tunca B.
Turkish Journal of Molecular Biology Biotechnology, vol.2, no.01, pp.98, 2017 (TRDizin) Sustainable Development

The Cytotoxic and Apoptotic Effects of Usnic Acid on Prostate Cancer versus Normal Cells

ERYILMAZ I. E., GÜNEY G., YURDACAN B., EGELİ Ü., ÇEÇENER G., TUNCA B.
Proceedings, vol.1, no.10, pp.1027, 2017 (Peer-Reviewed Journal) Sustainable Development

In Vitro Cytotoxic Effect Evaluation of Dioscorea communis (L.) Caddick Wilkin Rhizome and Stem Extracts on Hepatocellular Carcinoma Cells

EGELİ Ü., YURDACAN B., HURİYET H., GÜNEY G., ERYILMAZ I. E., ÇAVAŞ T., et al.
Proceedings, vol.1, no.10, pp.1011, 2017 (Peer-Reviewed Journal)

Investigation of Apoptotic Effects of Usnic Acid on Hepatocellular Carcinoma

YURDACAN B., EGELİ Ü., GÜNEY G., ERYILMAZ I. E., ÇEÇENER G., TUNCA B.
Proceedings, vol.1, no.10, pp.1010, 2017 (Peer-Reviewed Journal)

An in vitro model for the development of acquired tamoxifen resistance

Eskiler G. G., ÇEÇENER G., TUNCA B., EGELİ Ü.
CELL BIOLOGY AND TOXICOLOGY, vol.32, no.6, pp.563-581, 2016 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

The effect of solid lipid nanoparticles on tamoxifen-resistant breast cancer cells

Eskiler G. G., ÇEÇENER G., Dikmen G., Genc L., EGELİ Ü.
International Journal of Pharmacy and Pharmaceutical Sciences, vol.8, pp.43-46, 2016 (Scopus) Sustainable Development identifier

Circulating miR-195 as a therapeutic biomarker in turkish breast cancer patients

ÇEÇENER G., Ak S., Eskiler G. G., Demirdogen E., ERTÜRK BAKIR E., GÖKGÖZ M. Ş., et al.
Asian Pacific Journal of Cancer Prevention, vol.17, no.9, pp.4241-4246, 2016 (Scopus) Sustainable Development identifier identifier

The Anticancer Activity of Complex [Cu-2(mu-(C6H5)(2)CHCOO)(3)(bipy)(2))](ClO4) -Solid Lipid Nanoparticles on MCF-7 Cells

KANİ İ., DİKMEN G., Eskiler G. G., ÇEÇENER G., TUNCA B., EGELİ Ü.
CURRENT DRUG DELIVERY, vol.13, no.8, pp.1339-1350, 2016 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Frame-Shift Mutations in BRCA1 and BRCA2 Genes in Turkish Families with Breast and/or Ovarian Cancer

Cecener G.
ADVANCES IN GENETICS RESEARCH, VOL 2, vol.2, pp.121-128, 2010 (SCI-Expanded) Sustainable Development identifier identifier identifier

Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer

ÇEÇENER G., TUNCA B., EGELİ Ü., KARADAĞ M., VATAN Ö., Uzaslan E., et al.
TUMORI, vol.94, no.6, pp.845-848, 2008 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Importance of novel sequence alterations in the FHIT gene on formation of breast cancer

ÇEÇENER G., Egeli Ü., TUNCA B., Tasdelen I., TOLUNAY Ş., Bilgel N.
TUMORI J, vol.93, no.6, pp.597-603, 2007 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.

Egeli Ü., Cecener G., Tunca B., Tasdelen I.
Cancer investigation, vol.24, no.5, pp.484-91, 2006 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Common fragile site expression and genetic predisposition to breast cancer.

Cecener G., Egeli Ü., Tasdelen I., Tunca B., Duman H., Kizil A.
Teratogenesis, carcinogenesis, and mutagenesis, vol.18, no.6, pp.279-91, 1998 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

The expression of common fragile sites and genetic predisposition to squamous cell lung cancers.

Egeli Ü., Karadag M., Tunca B., Ozyardimci N.
Cancer genetics and cytogenetics, vol.95, no.2, pp.153-8, 1997 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Detection of fragile sites induced by pyrimethamine.

Egeli Ü., Tunca B.
Teratogenesis, carcinogenesis, and mutagenesis, vol.17, no.2, pp.59-69, 1997 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

Papers Published in Refereed Scientific Meetings

Therapeutic potential of BMN 673 loaded solid lipid nanoparticles in triple negative breast cancer

GÜNEY G., ÇEÇENER G., EGELİ Ü., TUNCA B.
NANO-2018, Ukraine, 27 - 30 August 2018, (Summary Text) Sustainable Development

Potential role of solid lipid nanoparticles in overcoming the acquired tamoxifen resistance of breast cancers

ÇEÇENER G., GÜNEY ESKİLER G., EGELİ Ü., TUNCA B.
European Biotechnology Congress 2017, 25 - 27 May 2017, (Summary Text) Sustainable Development

Cabazitaxel’in prostat kanserindeki apoptotik etkinliğinin prooksidan etkileri ile ilişkisi

Eryılmaz I. E., Egeli Ü., Çeçener G.
XVII. Tıbbi Biyoloji ve Genetik Kongresi, 28 - 31 October 2021, vol.52, pp.157-158, (Summary Text) Sustainable Development

Hedefe yönelik tedavi seçimi için üçlü negatif meme kanseri alt tiplerinden luminal androjen reseptörü (LAR) alt tipinin belirlenmesi

Tezcan Ünlü H., Ünal U., Çeçener G., Öztürk Nazlıoğlu H., Efendi Erdem E., Egeli Ü., et al.
XVII. Tıbbi Biyoloji ve Genetik Kongresi, İstanbul, Turkey, 28 - 31 October 2021, vol.52, no.1, pp.240-241, (Summary Text) Sustainable Development

The role of multidrug resistance in PARP inhibitor-resistant triple negative breast cancer cells

GÜNEY G., ÇEÇENER G., EGELİ Ü., TUNCA B.
6th International BAU Drug Design Congress, 13 - 15 December 2018, (Summary Text) Sustainable Development

Potential role of solid lipid nanoparticles in overcoming the acquired tamoxifen resistance of breast cancer

ÇEÇENER G., Eskiler G. G., EGELİ Ü., TUNCA B.
European Biotechnology Congress, Dubrovnik, Croatia, 25 - 27 May 2017, vol.256, (Summary Text) Sustainable Development identifier

Türk Pediatrik Akut Lenfoblastik Lösemi Vakalarında Philadelphia Benzeri Alt Grubun Tanımlanması

Efendi E., ÇEÇENER G., baytan b., EGELİ Ü., TUNCA B., Ünal U., et al.
XVI. TIBBİ BİYOLOJİ ve GENETİK KONGRESİ, 27 - 30 October 2019, (Summary Text)

The potentials of AR, AR-regulated TMPRSS2-ERG fusion and KLK3 mRNAs for prostate cancer risk assessment in suspicious prostate biopsy cores with atypical small acinar proliferation

ERYILMAZ I. E., KAYGISIZ O., AYTAÇ VURUŞKAN B., EGELİ Ü., TUNCA B., KORDAN Y., et al.
10th European Multidisciplinary Congress on Urological Cancers, Amsterdam, Netherlands, 8 - 11 November 2018, vol.17, pp.2889, (Summary Text) Sustainable Development

Cu2 C6H5 2CHCOO 3 bipy 2 ClO4 The potential cytotoxic and apoptotic effects of developed SLNs formulation as drug delivery system

GÜNEY G., ÇEÇENER G., KANİ İ., DİKMEN B., TUNCA B., EGELİ Ü.
Anticancer Drug Action and Drug Resistance: from Cancer Biology to the Clinic, Italy, 20 - 23 June 2015

A novel Zn(II) complex loaded solid lipid nanoparticles for breast cancer treatment: Synthesis, characterization and cytotoxic studies

GÜNEY G., ÇEÇENER G., KANİ İ., DİKMEN G., EGELİ Ü., TUNCA B.
NANO-2018, 27 - 30 August 2018, (Summary Text) Sustainable Development

Berrak Hücreli Tip Renal Hücreli Karsinom Hastaları için Potansiyel Prognostik Biyobelirteç Olarak KAT5 Geni ve Mir‐22’nin Değerlendirilmesi.

Ünal U., Tezcan Ünlü H., Çeçener G., Efendi Erdem E., Aytaç Vuruşkan B., Egeli Ü., et al.
8.Multidisipliner Kanser Araştırma Kongresi , İstanbul, Turkey, 15 - 17 January 2021, pp.1, (Summary Text)

MicroRNA-let-7a functions as a tumor suppressor and inhibits cancer stem cell growth in triple negative breast cancer by targeting PIK3CA

TEZCAN H., ÇEÇENER G., EGELİ Ü., TUNCA B.
3. Uluslararası Katılımlı Kök Hücre ve Hücresel Tedaviler Kongresi “Joint Meeting With ISSCA”, İstanbul, Turkey, 12 April - 14 February 2019, (Summary Text) Sustainable Development

The potential role of miR 143 targeted FHIT gene in breast cancer cells

ÇEÇENER G., GÜNEY G., Elif D., EGELİ Ü., TUNCA B.
Anticancer Drug Action and Drug Resistance: from Cancer Biology to the Clinic, Italy, 20 - 23 June 2015 Sustainable Development

METASTATİK PROSTAT KANSERİNDE CABAZİTAXEL ETKİNLİĞİNİ AZALTAN YENİ BİR MEKANİZMA:EDİNİLMİŞ REDOKS DİRENCİ

Eryılmaz I. E., Egeli Ü., Çeçener G.
15. Üroonkoloji Kongresi, Antalya, Turkey, 10 - 14 November 2021, (Summary Text) Sustainable Development

Investigation of Expression Levels of VHL, HIF1A and KAT 5 Genes in Clear Cell Renal Cell Carcinoma

Ünal U., ÇEÇENER G., AYTAÇ VURUŞKAN B., tezcan h., Efendi E., EGELİ Ü., et al.
16. TIBBİ BİYOLOJİ ve GENETİK KONGRESİ, 27 - 30 October 2019, (Summary Text)

LOKAL İLERİ PROSTAT KANSERLERİNDE SPINK1 EKSPRESYON ARTIŞININ BİYOKİMYASAL REKÜRRENS İLE İLİŞKİSİ

ERYILMAZ I. E., KAYGISIZ O., ÇEÇENER G., AYTAÇ VURUŞKAN B., EGELİ Ü., TUNCA B., et al.
14th International Urooncology Congress, Antalya, Turkey, 6 - 10 November 2019, pp.27, (Summary Text) Sustainable Development

Solid Lipid Nanoparticles in Reversing The Acquired Tamoxifen -Resistance

Eskiler G. G., ÇEÇENER G., EGELİ Ü., TUNCA B.
6th IEEE International Conference on E-Health and Bioengineering (EHB), Sinaia, Romania, 22 - 24 June 2017, pp.177-180, (Full Text) Sustainable Development identifier identifier

Triple Negatif Meme Kanserinde Talazoparib Direnci: MikroRNA Ekspresyon Profili

GÜNEY G., ÇEÇENER G., EGELİ Ü., TUNCA B.
23. Ulusal Kanser Kongresi, Turkey, 17 - 21 April 2019, (Summary Text) Sustainable Development

The Cytotoxic and Apoptotic Effects of The Young Shoots Extract of Tamus Communis on Hepatocellular Carcinoma

EGELİ Ü., YURDACAN B., HURİYET H., GÜNEY G., ERYILMAZ I. E., MALYER H., et al.
I.INTERNATIONAL CONGRESS ON MEDICINAL AND AROMATIC PLANTS ”NATURAL AND HEALTHY LiFE, 10 - 12 May 2017, (Full Text)

A synergistic apoptotic effect of combined treatment usnic acid with tamoxifen in breast cancer

GÜNEY G., ERYILMAZ I. E., YURDACAN B., EGELİ Ü., ÇEÇENER G., TUNCA B.
6th International BAU Drug Design Congress, 13 - 15 December 2018, (Summary Text) Sustainable Development

miRNA ve Kanser

ÇEÇENER G.
Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Fethiye, Turkey, 26 - 29 October 2017, pp.37-39, (Full Text) Sustainable Development

Promising anticancer effects of usnic acid in breast cancer

GÜNEY G., ERYILMAZ I. E., EGELİ Ü., YURDACAN B., ÇEÇENER G., TUNCA B.
International Congress for Applied Biological Sciences (ICABS 2018), 3 - 05 May 2018, (Summary Text) Sustainable Development

ÜSNİK ASİT VE CABAZİTAXEL’İN METASTATİK KASTRASYONA DİRENÇLİ PROSTAT KANSERİ HÜCRELERİNDE ANTİTÜMÖRAL KOMBİN ETKİLERİ

Colakoglu Bergel C., Eryılmaz I. E., Bulut E., Balaban R., Çeçener G., Egeli Ü.
5. Uluslararası Tıp Bilimleri ve Multidisipliner Yaklaşımlar Kongresi, Bursa, Turkey, 8 - 09 October 2022, pp.416, (Summary Text) Sustainable Development

The molecular consequences of the novel speckle-type POZ protein (SPOP) gene mutations at the protein level: A prostate cancer perspective

ERYILMAZ I. E., AYTAÇ VURUŞKAN B., KAYGISIZ O., ÇEÇENER G., EGELİ Ü., VURUŞKAN H.
European Human Genetics Virtual Conference, 28 August 2021, (Summary Text) Sustainable Development

The apoptotic effects of tamoxifen loaded solid lipid nanoparticles on breast cancer cells

ÇEÇENER G., GÜNEY G., GENÇ L., DİKMEN G., EGELİ Ü., TUNCA B.
A Matter of Life or Death: Mechanisms and Relevance of Cell Death for Cancer Biology and Treatment, 28 - 30 January 2016, (Full Text) Sustainable Development

TAMOKSİFEN TEDAVİSİ ALAN MEME KANSERLİ HASTALARDA CYP2D6 POLİMORFİZMLERİNİN TEDAVİ YANITINA ETKİSİ

sabour m., sabour l., ÇEÇENER G., tezcan h., TEZCAN G., EGELİ Ü., et al.
15. ULUSAL MEME HASTALIKLARI KONGRESİ, Turkey, 17 - 20 October 2019, (Summary Text) Sustainable Development

mikroRNA-216b, KRAS 3’UTR Bölgesini Hedefleyerek MemeKanseri Hücrelerinin Büyümesini İnhibe Eder

tezcan h., ÇEÇENER G., TAŞAR P., EGELİ Ü., TUNCA B., GÖKGÖZ M. Ş.
16. Tıbbi Biyoloji ve Genetik Kongresi, 27 - 30 October 2019, (Summary Text)

The importance of genetic counselling and BRCA1 2 mutation testing on breast cancer patients

ÇEÇENER G., GÜNEY G., TUNCA B., EGELİ Ü.
2016 International Congresses on Education ERPA, 2 - 04 June 2016, (Full Text) Sustainable Development

Nrf2-mediated Disruption of Redox Adaptation by Cabazitaxel in Metastatic Prostate Cancer

ERYILMAZ I. E., EGELİ Ü., ÇEÇENER G.
EACR 2021 Virtual Congress: Better Outcomes Through Research, United Kingdom, 09 June 2021, (Summary Text) Sustainable Development

Erken Yaş Meme Kanserli Hastalarda CHEK2 GenindekiGenetik Varyasyonların Değerlendirilmesi

TEZCAN H., AKSOY F., GÜNEY G., ÇEÇENER G., EGELİ Ü., TUNCA B., et al.
XIV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2015 Sustainable Development

Antiviral RdRp İnhibitörü Remdesivir’in Kanser Hücrelerinde Hücre Ölümü Üzerine Etkilerinin Araştırılması

Eryılmaz I. E., Çolakoğlu Bergel C., Egeli Ü., Çeçener G.
24. Ulusal Kanser Kongresi , Ankara, Turkey, 9 - 13 November 2022, pp.9-10, (Summary Text) Sustainable Development

Erken Yaş ve veya Ailesel Meme Kanseri Hastalarında Genetik Yatkınlığın Önemi Uludağ Üniversitesi Tıp Fakültesi Genel Cerrahi Tıbbi Biyoloji Ana Bilim Dalı Verileri

ÇEÇENER G., GÜNEY G., GÖKGÖZ M. Ş., EGELİ Ü., TUNCA B.
13. Ulusal Meme Hastalıkları” kongresi, Turkey, 21 - 25 October 2015, (Summary Text) Sustainable Development

Evaluation of combined antitumoral effect of usnic acid and MDV3100 (Enzalutamide) on hormone-dependent prostate cancer cells

ERYILMAZ I. E., GÜNEY G., EGELİ Ü., YURDACAN B., ÇEÇENER G., TUNCA B.
IV. International Congress for Applied Biological Sciences (ICABS 2018), 3 - 05 May 2018, (Summary Text) Sustainable Development

Transcriptional regulation of RNAs in androgen receptor axis by apigenin compared to cabazitaxel efficiency in prostate cancer cells

ERYILMAZ I. E., EGELİ Ü., ÇEÇENER G., TUNCA B.
11th European Multidisciplinary Meeting on Urological Cancers (EMUC), 13 - 17 November 2019, vol.18, pp.3487, (Summary Text) Sustainable Development

Lokal ileri prostat kanserlerinde novel Speckle-type POZ Protein (SPOP) mutasyonları

ERYILMAZ I. E., KAYGISIZ O., ÇEÇENER G., AYTAÇ VURUŞKAN B., EGELİ Ü., TUNCA B., et al.
16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2019, (Summary Text) Sustainable Development

In Vitro Cytotoxic and Antitumoral Effects of Juniperus communis Leaf and Berry Extracts on Castration-Resistant Prostate Cancer Cells

ERYILMAZ I. E., EGELİ Ü., ÇEÇENER G., TUNCA B., ŞAHİN S., MALYER H.
15th International Congress of Histochemistry and Cytochemistry “From Molecules to Diseases”, 18 - 21 May 2017, (Summary Text) Sustainable Development

Cytotoxicity of Juniperus excelsa Aqueous Berry Extract on Castration-Resistant Prostate CancerCells

ERYILMAZ I. E., EGELİ Ü., MALYER H., ÇEÇENER G., ŞAHİN S., TUNCA B.
VI. International Congress of Molecular Medicine, 22 - 25 May 2017, (Summary Text) Sustainable Development

Combination treatment of usnic acid and sorafenib on hepatocellular carcinoma

YURDACAN B., EGELİ Ü., GÜNEY ESKİLER G., ERYILMAZ I. E., ÇEÇENER G., TUNCA B.
Erciyes Tıp Genetik Günleri 2019, Turkey, 21 - 23 February 2019, (Summary Text)

Synthetic lethal effects of BMN 673 loaded solid lipid nanoparticles on triple-negative breast cance

GÜNEY G., ÇEÇENER G., EGELİ Ü., TUNCA B.
MAP 2018 – Molecular Analysis for Personalised Therapy, 14 - 15 September 2018, (Summary Text)

Metastatik prostat kanseri için redoks adaptasyonu geliştirilmiş bir in vitro model oluşturulması ve karakterize edilmesi

Eryılmaz I. E., Egeli Ü., Çeçener G.
XVII. Tıbbi Biyoloji ve Genetik Kongresi, 28 - 31 October 2021, vol.52, pp.155-156, (Summary Text) Sustainable Development

Alfa talaseminin moleküler tanısında direkt sekans yöntemi: revize metodoloji

ERYILMAZ I. E., baytan b., ünal u., efendi e., tezcan h., ÇEÇENER G., et al.
16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2019, (Summary Text)

Tamoxifen loaded solid lipid nanoparticles in reversing of tamoxifen-resistance: microRNA expression profiles

GÜNEY G., ÇEÇENER G., EGELİ Ü., TUNCA B.
IV. International Congress for Applied Biological Sciences (ICABS 2018), 3 - 05 May 2018, (Summary Text)

ÜSNİK ASİTİN OTOFAJİK ETKİSİNİN MALİGN MELANOM HÜCRELERİNDE QRT-PCR İLE DEĞERLENDİRİLMESİ

Colakoglu Bergel C., Eryılmaz I. E., Egeli Ü., Çeçener G.
5. Uluslararası Tıp Bilimleri ve Multidisipliner Yaklaşımlar Kongresi, Bursa, Turkey, 8 - 09 October 2022, pp.417, (Summary Text) Sustainable Development

Books & Book Chapters

Frame-shift Mutations in BRCA1 and BRCA2 genes in Turkish families with Breast and/or Ovarian Cancer

Çeçener G.
in: Advances in Genetics Research, Kevin V. Urbano, Editor, NOVA Science Publishers Inc. , New York, pp.121-128, 2010 Sustainable Development